BIT:DIAMedical Equipment
DiaSorin Reshapes Global Footprint As Market Weighs US Gains And China Exit
DiaSorin is expanding its US hospital footprint through new distribution agreements with Fisher Scientific and McKesson.
The company is restructuring its China operations, including the closure of its Shanghai manufacturing site.
These moves reshape DiaSorin's global setup and could influence how its immuno franchise is positioned in key markets.
DiaSorin (BIT:DIA), trading at around €63.76, has been under pressure, with the share price down 32.0% over the past year and 51.7% over five...